Choose Hope...it's in his genes

Inspired by Hope and Driven by Love

This past April, Mike and Katie received the news no parent wants to hear. Their 15-month-old, Collin, was diagnosed with a genetic disease so rare there’s not even a name for it. The doctor simply called it MED13L, for the type of gene mutation. The doctor explained children with MED13L have intellectual disabilities, severe language delays, seizures, heart defects and low muscle tone. There have been less than 1,000 cases reported. Currently, there are no treatments or cures.

As Collin smiled up at his parents, Mike and Katie made the decision to CHOOSE HOPE. Since this decision, Mike and Katie have taken a crash court in genetics, spent countless hours emailing and zooming with doctors and scientists involved in MED13L research, fundraised, traveled to Baltimore and New York to participate in research studies and joined the MED13L Foundation Board of Trustees. The Foundation has tapped into the new technologies that offer up hope for transforming the lives of MED13L children. Costs are staggering and there is no readily available government or industry funding. Our focus is to find a treatment and cure for MED13L but we envision our research helping all children with rare genetic disorders.

We ask today to CHOOSE HOPE for Collin with us!